Back to Search Start Over

Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease

Authors :
María-Jesús Pinazo
Igor C. Almeida
Montserrat Gállego
Cameron C. Ellis
Ana García-Álvarez
Joaquim Gascon
Cristina Ballart
Maria Tays Mendes
Clara Mazagatos
Carmen Fernandez-Becerra
Nuria Cortes-Serra
Joan Segui-Barber
Ministerio de Ciencia, Innovación y Universidades (España)
Fundación La Marató TV3
Fundación Mundo Sano
European Regional Development Fund
Redes Temáticas de Investigación Cooperativa en Salud
Red de Investigación Cooperativa en Enfermedades Tropicales
Red Iberoamericana Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas
NIH - National Institute on Minority Health and Health Disparities (NIMHD) (Estados Unidos)
Government of Catalonia (España)
Source :
Repisalud, Instituto de Salud Carlos III (ISCIII), Dipòsit Digital de la UB, Universidad de Barcelona, Emerging Infectious Diseases, Emerging Infectious Diseases, Vol 26, Iss 8, Pp 1846-1851 (2020)
Publication Year :
2020
Publisher :
Centers for Disease Control and Prevention (CDC), 2020.

Abstract

Chagas disease is emerging in countries to which it is not endemic. Biomarkers for earlier therapeutic response assessment in patients with chronic Chagas disease are needed. We profiled plasma-derived extracellular vesicles from a heart transplant patient with chronic Chagas disease and showed the potential of this approach for discovering such biomarkers. Barcelona Institute for Global Health (ISGlobal) receives support from the Spanish Ministry of Science, Innovation and Universities through the Centro de Excelencia Severo Ochoa 2019–2023 Program (CEX2018-000806-S). ISGlobal and Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP) are members of the Centres de Recerca de Catalunya (CERCA Program), Generalitat de Catalunya. Work in the laboratory of C.F.B. is funded by Fundació La Marató de TV3 (reference 566/U/2018) and Fundación Mundo Sano. This project was co-financed by the European Union through the European Regional Development Fund with the support of Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya. N.C., M.G., J.G., and M.J.P. receive funds from the Redes temáticas de investigación cooperativa en salud (RETICS), Spanish Tropical Diseases Network “RD12/0018/0010” and from the Agencia de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya; grant “2017 SGR 00924.” M.G., C.B., J.G., M.J.P., and I.C.A. belong to the Ibero-American Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas network. I.C.A. is partially supported by grants no. 2G12MD007592 and 5U54MD007592 from the National Institute on Minority Health and Health Disparities of the US National Institutes of Health. We are grateful to the Biomolecule Analysis Core Facility at University of Texas at El Paso, Border Biomedical Research Center, funded by National Institute on Minority Health and Health Disparities grants 2G12MD007592 and 5U54MD007592. M.T.M. received a PhD fellowship from the Science Without Borders Program, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil. Sí

Details

Database :
OpenAIRE
Journal :
Repisalud, Instituto de Salud Carlos III (ISCIII), Dipòsit Digital de la UB, Universidad de Barcelona, Emerging Infectious Diseases, Emerging Infectious Diseases, Vol 26, Iss 8, Pp 1846-1851 (2020)
Accession number :
edsair.doi.dedup.....e3ef0a9ff2565f54df383dc44180b3e3